35
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Efficacy and Toxicity of Liposomal Daunorubicin Included in PVABEC Regimen for Aggressive NHL of the Elderly

, , , &
Pages 465-469 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tao Chen, Deirdre Mcintosh, Yuehua He, Jungsoo Kim, David A. Tirrell, Peter Scherrer, David B. Fenske, Ammen P. Sandhu & Pieter R. Cullis. (2004) Alkylated derivatives of poly(ethylacrylic acid) can be inserted into preformed liposomes and trigger pH-dependent intracellular delivery of liposomal contents. Molecular Membrane Biology 21:6, pages 385-393.
Read now

Articles from other publishers (6)

P.-L. Lam, K. K.-H. Lee, Y.-W. Ho, R. S.-M. Wong, S.-W. Tong, C.-H. Cheng, K.-H. Lam, J. C.-O. Tang, Z.-X. Bian, R. Gambari, S. H.-L. Kok & C.-H. Chui. (2014) The development of chitosan based microcapsules as delivery vehicles for orally administered daunorubicin. RSC Advances 4:27, pages 14109.
Crossref
Melani Solomon & Gerard G. M. D’Souza. 2011. Intracellular Delivery. Intracellular Delivery 57 72 .
Donald J. AbrahamIjeoma F. Uchegbu & Andreas G. Schatzlein. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 469 492 .
Matteo Pelosini, Daniele Focosi, Fazzi Rita, Sara Galimberti, Francesco Caracciolo, Edoardo Benedetti, Federico Papineschi & Mario Petrini. (2007) Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature. Annals of Hematology 87:5, pages 405-412.
Crossref
David S. Alberts, Franco M. Muggia, James Carmichael, Eric P. Winer, Mohammad Jahanzeb, Alan P. Venook, Keith M. Skubitz, Edgardo Rivera, Joseph A. Sparano, Nicholas J. Dibella, Simon J. Stewart, John J. Kavanagh & Alberto A. Gabizon. (2004) Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials. Seminars in Oncology 31, pages 53-90.
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:2, pages 91-98.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.